Our endometrial carcinoma analysis offered especially interesting results as it returned numerous pairs of networks with similarity, where most of the corresponding genes in these pairs - such as CTCF, NAV3, and ZFHX3 - are not typically implicated as markers of drug response. Here, NAV3 is linked to endometrial carcinoma.